title: Gene therapy: science in slow motion.
abstract: Early-stage human trials of gene therapies that could target some of the world's deadliest diseases are underway. An air of caution lingers, however, as past setbacks remain on investors' minds. Researchers are optimistic about the potential for positive outcomes that could lure biotech companies back.
authors: John
authors: J
authors: Carroll